Glaukos Corporation

This study tests whether adding a tiny travoprost-releasing implant (iDose TR) to an existing drainage implant (iStent infinite) lowers eye pressure better than the drainage implant alone. About 230 adults with open-angle glaucoma or high eye pressure will be followed for 12 mont…

This study tests an experimental eye drop called GLK-321 for people with Demodex blepharitis, an eyelid condition caused by tiny mites. About 250 adults with signs of the condition will receive either the drug or a placebo for 6 weeks. The main goal is to see if the drops can cle…

This Phase 3 trial tests a tiny implant placed inside the eye that slowly releases travoprost, a drug to lower eye pressure. The goal is to see if it works as well as daily eye drops for people with open-angle glaucoma or high eye pressure. About 510 adults will take part, and th…

This study tests a tiny implant placed inside the eye that slowly releases travoprost, a drug that lowers eye pressure. The goal is to see if it works better than daily eye drops for people with open-angle glaucoma or high eye pressure. About 610 adults will take part, and the im…

This study tests whether a small implant placed inside the eye during cataract surgery can safely lower eye pressure in people with glaucoma or high eye pressure. About 132 adults will receive either the implant plus surgery or surgery alone. The goal is to see if the implant hel…

This study tests an experimental eye drop called GLK-221 for people with keratoconus, a condition where the cornea thins and bulges into a cone shape, blurring vision. The trial will enroll 100 adults aged 18 to 55 and compare the eye drop to a placebo over several months. The ma…

This study tests an updated inserter for a travoprost implant that is placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 30 adults will take part to see if doctors can successfully use the new inserter as instructed. The goal …